Comparable stake leader
Tasso Partners, LLC
SEC ownership of PAVmed Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001624326.
Disclosed value leader
Two Seas Capital LP
Comparable rows
18/40
Latest evidence
02 Apr 2026
- Public ticker
- PAVM on Nasdaq
- Parsed ownership sources
-
13D/G, 3/4/5, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Tasso Partners, LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
18 of 40
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Tasso Partners, LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
02 Apr 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001624326
- Issuer location
- New York, NY
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of PAVmed Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Tasso Partners, LLC
Disclosed value leader
Two Seas Capital LP
Comparable rows
18/40
Latest evidence
02 Apr 2026
13D/G
3/4/5
13F
Lead comparable stake: 15%
22 rows are not safely comparable across share classes.
13D/G row: Tasso Partners, LLC
Showing 1-8 of 40 holder rows.
Quick read
Tasso Partners, LLC leads the comparable SEC ownership view at 15%.
18 of 40 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Tasso Partners, LLC's linked filing trail.
Comparable ownership
Top 5
Tasso Partners, LLC
15%
Two Seas Capital LP
10%
Ayrton Capital LLC
10%
Scopia Holdings LLC
9.9%
FIRST MANHATTAN CO. LLC.
9.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 40 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Tasso Partners, LLC |
13D/G
3/4/5
Dana Carrera · 10%+ Owner
|
15%
|
$215,114
974,246 shares
|
-$353,303 | 27 Mar 2026 |
| Two Seas Capital LP |
13F
13D/G
Company
|
10%
from 13D/G
|
$4,684,621
461,539 shares
|
— | 31 Mar 2026 |
| Ayrton Capital LLC |
13D/G
|
10%
|
$170,177
709,069 shares
|
-$124,139 | 31 Mar 2026 |
| Scopia Holdings LLC |
13D/G
Matthew Sirovich
|
9.9%
|
$140,798
637,670 shares
|
$0 | 27 Mar 2026 |
| FIRST MANHATTAN CO. LLC. |
13F
13D/G
Company
|
9.6%
from 13D/G
|
$241,621
23,805 shares
|
— | 31 Mar 2026 |
| David S. Nagelberg |
13D/G
NAGELBERG DAVID S
|
8.6%
|
$120,770
546,964 shares
|
$0 | 27 Mar 2026 |
| Kallman Craig |
13D/G
|
6%
|
$84,923
384,616 shares
|
$0 | 27 Mar 2026 |
| Sargent Investment Group, LLC |
13D/G
|
5.8%
|
$604,183
1,006,300 shares
|
$0 | 01 Jul 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 03 Aug 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-14 of 14 reporting-owner rows connected to PAVmed Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
14
Largest Forms 3/4/5 holder
Tasso Partners, LLC
Net 12M change
$0
Latest report
02 Apr 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Tasso Partners, LLC | 10%+ Owner | $201,589 | Mixed | 27 Mar 2026 | ||
| Aklog Lishan | Chairman and CEO, Director | $81,158 | Mixed | 02 Apr 2026 | ||
| Dennis M. Mcgrath | President and CFO | $41,222 | Mixed | 02 Apr 2026 | ||
| Joan B. Harvey | Director | $40,508 | Mixed | 22 Feb 2024 | ||
| James L. Cox | Director | $40,508 | Mixed | 22 Feb 2024 | ||
| Shaun O'Neil | Chief Operating Officer | $25,524 | Mixed | 02 Apr 2026 | ||
| Michael A. Gordon | General Counsel | $25,392 | Mixed | 02 Apr 2026 | ||
| Victoria Tou-Ho Lee | Chief Medical Officer | $15,823 | Mixed | 02 Apr 2026 | ||
| Michael J. Glennon | Director | $4,780 | Mixed | 02 Apr 2026 | ||
| Timothy E. Baxter | Director | $4,658 | Mixed | 02 Apr 2026 | ||
| Ronald M. Sparks | Director | $4,658 | Mixed | 02 Apr 2026 | ||
| Debra White | Director | $4,658 | Mixed | 02 Apr 2026 | ||
| Sundeep Agrawal | Director | $4,269 | Mixed | 02 Apr 2026 | ||
| Brian J. DeGuzman | Chief Medical Officer | Mixed | 18 Feb 2022 |
Recent insider transactions for PAVmed Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Victoria Tou-Ho Lee | PAVM | Common Stock | Award | 4201.7% | 70,000 | 71,666 | 02 Apr 2026 | Direct | ||
| Lishan Aklog | PAVM | Common Stock | Award | 4596.8% | 350,000 | 357,614 | 02 Apr 2026 | Direct | ||
| Dennis M. Mcgrath | PAVM | Common stock | Award | 2688.6% | 180,000 | 186,695 | 02 Apr 2026 | Direct | ||
| Michael J. Glennon | PAVM | Common stock | Award | 180.4% | 13,930 | 21,653 | 02 Apr 2026 | Direct | ||
| Timothy E. Baxter | PAVM | Common stock | Award | 194.4% | 13,930 | 21,097 | 02 Apr 2026 | Direct | ||
| Debra White | PAVM | Common Stock | Award | 194.4% | 13,930 | 21,097 | 02 Apr 2026 | Direct | ||
| Ronald M. Sparks | PAVM | Common stock | Award | 194.4% | 13,930 | 21,097 | 02 Apr 2026 | Direct | ||
| Sundeep Agrawal | PAVM | Common Stock | Award | 257.6% | 13,930 | 19,337 | 02 Apr 2026 | Direct | ||
| Michael A. Gordon | PAVM | Common stock | Award | 2200% | 110,000 | 115,000 | 02 Apr 2026 | Direct | ||
| Shaun O'Neil | PAVM | Common Stock | Award | 1965% | 110,000 | 115,598 | 02 Apr 2026 | Direct | ||
| Ronald M. Sparks | PAVM | Common stock | Award | 230.8% | 150,000 | 215,000 | 30 Sep 2025 | Direct | ||
| Debra White | PAVM | Common stock | Award | 230.8% | 150,000 | 215,000 | 30 Sep 2025 | Direct | ||
| Timothy E. Baxter | PAVM | Common stock | Award | 230.8% | 150,000 | 215,000 | 30 Sep 2025 | Direct | ||
| Michael J. Glennon | PAVM | Common stock | Award | 183.7% | 150,000 | 231,667 | 30 Sep 2025 | Direct | ||
| Sundeep Agrawal | PAVM | Common Stock | Award | 1230% | 150,000 | 162,195 | 30 Sep 2025 | Direct | ||
| Michael A. Gordon | PAVM | Common Stock | Award | 150,000 | 150,000 | 30 Sep 2025 | Direct | |||
| Dennis M. Mcgrath | PAVM | Common Stock | Award | 295.1% | 150,000 | 200,834 | 30 Sep 2025 | Direct | ||
| Lishan Aklog | PAVM | Common Stock | Award | 191.3% | 150,000 | 228,418 | 30 Sep 2025 | Direct | ||
| Shaun O'Neil | PAVM | Common Stock | Award | 836.4% | 150,000 | 167,933 | 30 Sep 2025 | Direct |
* marks a reported price that did not pass the local price check.